CrossrefInfokarte
Durable Response After Pembrolizumab for Recurrent Tracheal Squamous Cell Carcinoma: A Case Report and Focused Literature Review
Clinical Lung Cancer · 2026-11 · 27 (9) · 34-38
DOI: 10.1016/j.cllc.2026.09.005 ↗Abstract
Kein Abstract verfügbar.
EUVIMED